Canopy Growth Corp Equity Method Investment, Other than Temporary Impairment
Canopy Growth Corp (CGC) reported Equity Method Investment, Other than Temporary Impairment of CAD 55.23 million for the 12-month period ending 2020-03-31, per its 10-K filed 2020-06-01.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2020-06-01
- Canopy Growth Corp equity method investment, other than temporary impairment for fiscal 2020 was 55.23M CAD.
| Period end | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|
| 2020-03-31 | 55.23M CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |